Valuation: Net Medical Xpress Solutions, Inc.

Market Cap 1.07M 927K 871K 792K 1.49M 103M 1.51M 10.21M 3.99M 51.41M 4.03M 3.94M 171M P/E 2015
32.9x
P/E 2016 -5.75x
Enterprise Value 827K 714K 671K 610K 1.15M 79.04M 1.17M 7.86M 3.07M 39.58M 3.1M 3.04M 132M EV / Sales 2015
1.04x
EV / Sales 2016 0.65x
Free-Float
100%
Yield 2015 *
-
Yield 2016 -
1 day+0.14%
1 week-0.14%
Current month-0.14%
6 months+40.00%
Current year+133.33%
1 month 0
Extreme 0.000701
0
Current year 0
Extreme 0.0004
0
1 year 0
Extreme 1.0E-6
0
3 years 0
Extreme 1.0E-6
0.03
5 years 0
Extreme 1.0E-6
0.75
10 years 0
Extreme 0
0.75
Manager TitleAgeSince
President - 26/06/2019
Director TitleAgeSince
Director/Board Member 64 01/01/2003
Director/Board Member 84 01/01/2005
Director/Board Member - 01/03/2018
Change 5-day change 1-year change 3-year change Capi.($)
+0.14%-0.14%+69,900.00%-96.50% 26.4K
-1.94%-3.33%-5.40%+54.38% 3,679B
+0.84%-0.22%+0.47%+1,135.62% 418B
-3.20%-4.48%+93.00%+175.89% 91.73B
+0.37%-1.09%-7.85%+49.02% 89.45B
-0.23%+2.67%-32.41%-0.33% 80.71B
-1.51%+5.25%-31.84%+205.96% 74.69B
-0.16%-2.72%+6.08%+78.65% 46.17B
-2.93%+4.20%-6.46%-14.62% 41.06B
-1.23%-6.54%+122.47%+298.27% 36.58B
Average -0.99%+2.16%+7,003.81%+188.63% 455.72B
Weighted average by Cap. -1.63%-0.32%-2.70%+159.05%

Financials

2015 2016
Net sales 4.22M 3.65M 3.43M 3.12M 5.86M 404M 5.96M 40.15M 15.7M 202M 15.85M 15.51M 672M 3.04M 2.63M 2.47M 2.25M 4.23M 291M 4.3M 28.96M 11.32M 146M 11.43M 11.18M 485M
Net income 151K 130K 123K 111K 210K 14.44M 213K 1.44M 561K 7.23M 567K 555K 24.03M -344K -297K -279K -254K -477K -32.89M -485K -3.27M -1.28M -16.47M -1.29M -1.26M -54.74M
Net Debt -340K -294K -276K -251K -472K -32.51M -480K -3.23M -1.26M -16.28M -1.28M -1.25M -54.1M -247K -213K -200K -182K -343K -23.62M -348K -2.35M -918K -11.83M -927K -907K -39.3M
Logo Net Medical Xpress Solutions, Inc.
Net Medical Xpress Solutions, Inc. focuses on the development of artificial intelligence software named PrivateAI (Private Eye), developing clinical trials, and expanding immune defense products to different markets. The Company is also focusing on productizing hand-labeled image data for use in artificial intelligence training, verification, and validation of custom models. It focuses on artificial intelligence for medical research, clinical trials, and Food and Drug Administration (FDA) compliance, which includes cybersecurity audit products designed to meet the FDA's new mandates for connected devices. Through its subsidiary, Immunity Science, Inc., the Company provides a variety of over-the-counter vitamins, supplements, air purifiers, nasal sprays, and drug-free pain patches. It offers its products through the Website www.immunityscience.store direct to consumers. In addition, products are available from distribution centers at retail locations.
Employees
23
  1. Stock Market
  2. Stocks
  3. NMXS Stock